OncoSec Medical Incorporated

OncoSec Medical Incorporatedverified

ONCS

Price:

$0.2772

Market Cap:

$1.65M

OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company's lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor. It is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in clinical trials collaboration and supply agreement (KEYNOTE-695) and metastatic triple negative breast cancer, which is in Phase II clinical trials (KEYNOTE-...[Read more]

Industry

Biotechnology

IPO Date

2010-04-07

Stock Exchange

NASDAQ

Ticker

ONCS

The PE Ratio as of July 2024 (TTM) for OncoSec Medical Incorporated (ONCS) is -0.01

According to OncoSec Medical Incorporated’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -98.12% compared to the average of -0.73 of the last 4 quarters.

OncoSec Medical Incorporated (ONCS) Historical PE Ratio (quarterly & annually)

How has ONCS PE Ratio performed in the past?

The mean historical PE Ratio of OncoSec Medical Incorporated over the last ten years is -2.31. The current -0.01 PE Ratio has changed -40.80% with respect to the historical average. Over the past ten years (40 quarters), ONCS's PE Ratio was at its highest in in the January 2023 quarter at -0.21. The PE Ratio was at its lowest in in the April 2014 quarter at -9.91.

Quarterly (TTM)
Annual

Average

-2.31

Median

-1.43

Minimum

-6.98

Maximum

-0.52

OncoSec Medical Incorporated (ONCS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of OncoSec Medical Incorporated PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 216.36%

Maximum Annual PE Ratio = -0.52

Minimum Annual Increase = -68.83%

Minimum Annual PE Ratio = -6.98

Quarterly (TTM)
Annual
YearPE RatioChange
2022-0.86-46.10%
2021-1.59-3.38%
2020-1.64216.36%
2019-0.52-59.13%
2018-1.2731.13%
2017-0.97-14.21%
2016-1.13-68.83%
2015-3.63-48.06%
2014-6.9856.12%
2013-4.47-25.35%

OncoSec Medical Incorporated (ONCS) Average PE Ratio

How has ONCS PE Ratio performed in the past?

The current PE Ratio of OncoSec Medical Incorporated (ONCS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.36

5-year avg

-1.18

10-year avg

-2.31

OncoSec Medical Incorporated (ONCS) PE Ratio vs. Peers

How is ONCS’s PE Ratio compared to its peers?

OncoSec Medical Incorporated’s PE Ratio is greater than ZyVersa Therapeutics, Inc. (-0.02), greater than Palisade Bio, Inc. (-0.25), greater than Unicycive Therapeutics, Inc. (-0.38), greater than Apexigen, Inc. (-0.36), greater than Immix Biopharma, Inc. (-2.68), less than Phio Pharmaceuticals Corp. (0), greater than 180 Life Sciences Corp. (-2.20), greater than Navidea Biopharmaceuticals, Inc. (-0.08), less than First Wave BioPharma, Inc. (0.03), greater than Dermata Therapeutics, Inc. (-0.85), greater than Revelation Biosciences, Inc. (-0.09), greater than Panbela Therapeutics, Inc. (-0.20), greater than ContraFect Corporation (-0.04), greater than Quoin Pharmaceuticals, Ltd. (-0.11), greater than Allarity Therapeutics, Inc. (-0.15), less than Kiromic BioPharma, Inc. (-0.00), greater than Virax Biolabs Group Limited (-0.12), greater than Biodexa Pharmaceuticals Plc (-0.30), greater than null (-0.12),

Build a custom stock screener for OncoSec Medical Incorporated (ONCS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OncoSec Medical Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OncoSec Medical Incorporated (ONCS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OncoSec Medical Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is OncoSec Medical Incorporated's PE Ratio?

How is the PE Ratio calculated for OncoSec Medical Incorporated (ONCS)?

What is the highest PE Ratio for OncoSec Medical Incorporated (ONCS)?

What is the 3-year average PE Ratio for OncoSec Medical Incorporated (ONCS)?

What is the 5-year average PE Ratio for OncoSec Medical Incorporated (ONCS)?

How does the current PE Ratio for OncoSec Medical Incorporated (ONCS) compare to its historical average?